314 related articles for article (PubMed ID: 36651824)
1. Core, Coating, or Corona? The Importance of Considering Protein Coronas in nano-QSPR Modeling of Zeta Potential.
Sengottiyan S; Mikolajczyk A; Jagiełło K; Swirog M; Puzyn T
ACS Nano; 2023 Feb; 17(3):1989-1997. PubMed ID: 36651824
[TBL] [Abstract][Full Text] [Related]
2. Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties.
Liu R; Jiang W; Walkey CD; Chan WC; Cohen Y
Nanoscale; 2015 Jun; 7(21):9664-75. PubMed ID: 25959034
[TBL] [Abstract][Full Text] [Related]
3. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
4. Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties.
Obst K; Yealland G; Balzus B; Miceli E; Dimde M; Weise C; Eravci M; Bodmeier R; Haag R; Calderón M; Charbaji N; Hedtrich S
Biomacromolecules; 2017 Jun; 18(6):1762-1771. PubMed ID: 28511014
[TBL] [Abstract][Full Text] [Related]
5. Iron Oxide Nanoparticle Coatings Dictate Cell Outcomes Despite the Influence of Protein Coronas.
Portilla Y; Mellid S; Paradela A; Ramos-Fernández A; Daviu N; Sanz-Ortega L; Pérez-Yagüe S; Morales MP; Barber DF
ACS Appl Mater Interfaces; 2021 Feb; 13(7):7924-7944. PubMed ID: 33587585
[TBL] [Abstract][Full Text] [Related]
6. A nanoinformatics decision support tool for the virtual screening of gold nanoparticle cellular association using protein corona fingerprints.
Afantitis A; Melagraki G; Tsoumanis A; Valsami-Jones E; Lynch I
Nanotoxicology; 2018 Dec; 12(10):1148-1165. PubMed ID: 30182778
[TBL] [Abstract][Full Text] [Related]
7. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
Shang L; Nienhaus GU
Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
[TBL] [Abstract][Full Text] [Related]
8. The curious cases of nanoparticle induced amyloidosis during protein corona formation and anti-amyloidogenic nanomaterials: Paradox or prejudice?
Randhawa S; Abidi SMS; Dar AI; Acharya A
Int J Biol Macromol; 2021 Dec; 193(Pt A):1009-1020. PubMed ID: 34728302
[TBL] [Abstract][Full Text] [Related]
9. Predicting electrophoretic mobility of TiO
Swirog M; Mikolajczyk A; Jagiello K; Jänes J; Tämm K; Puzyn T
Sci Total Environ; 2022 Sep; 840():156572. PubMed ID: 35710003
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.
Moraru C; Mincea M; Menghiu G; Ostafe V
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081296
[TBL] [Abstract][Full Text] [Related]
11. Protein corona: a new approach for nanomedicine design.
Nguyen VH; Lee BJ
Int J Nanomedicine; 2017; 12():3137-3151. PubMed ID: 28458536
[TBL] [Abstract][Full Text] [Related]
12. Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy.
Khan S; Sharifi M; Gleghorn JP; Babadaei MMN; Bloukh SH; Edis Z; Amin M; Bai Q; Ten Hagen TLM; Falahati M; Cho WC
J Control Release; 2022 Aug; 348():127-147. PubMed ID: 35660636
[TBL] [Abstract][Full Text] [Related]
13. The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum.
Mirshafiee V; Kim R; Mahmoudi M; Kraft ML
Int J Biochem Cell Biol; 2016 Jun; 75():188-95. PubMed ID: 26643610
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive investigation of the interactions of human serum albumin with polymeric and hybrid nanoparticles.
Ural MS; Joseph JM; Wien F; Li X; Tran MA; Taverna M; Smadja C; Gref R
Drug Deliv Transl Res; 2024 Aug; 14(8):2188-2202. PubMed ID: 38578378
[TBL] [Abstract][Full Text] [Related]
15. Plasma Parameters During Nanoparticle-Enhanced Laser-Induced Breakdown Spectroscopy (NELIBS) in the Presence of Nanoparticle-Protein Conjugates.
Dell'Aglio M; Mallardi A; Gaudiuso R; Giacomo A
Appl Spectrosc; 2023 Nov; 77(11):1253-1263. PubMed ID: 37700694
[TBL] [Abstract][Full Text] [Related]
16. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
[TBL] [Abstract][Full Text] [Related]
17. How protein coronas determine the fate of engineered nanoparticles in biological environment.
Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
[TBL] [Abstract][Full Text] [Related]
18. A health concern regarding the protein corona, aggregation and disaggregation.
Falahati M; Attar F; Sharifi M; Haertlé T; Berret JF; Khan RH; Saboury AA
Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):971-991. PubMed ID: 30802594
[TBL] [Abstract][Full Text] [Related]
19. Protein corona, understanding the nanoparticle-protein interactions and future perspectives: A critical review.
Kopac T
Int J Biol Macromol; 2021 Feb; 169():290-301. PubMed ID: 33340622
[TBL] [Abstract][Full Text] [Related]
20. Zwitterionic polymer ligands: an ideal surface coating to totally suppress protein-nanoparticle corona formation?
Debayle M; Balloul E; Dembele F; Xu X; Hanafi M; Ribot F; Monzel C; Coppey M; Fragola A; Dahan M; Pons T; Lequeux N
Biomaterials; 2019 Oct; 219():119357. PubMed ID: 31351245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
